Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NEWROFEED

Financiado

Cerrado

Personalized medical device for the diagnosis and treatment of ADHD based on EEG...

Personalized medical device for the diagnosis and treatment of ADHD based on EEG biomarkers and Neurofeedback Training NEWROFEED aims at setting a new standard of care for children suffering from Attention Deficit Hyperactivity Disorder (ADHD). ADHD@Home is the diagnosis and treatment medical device, developed by Mensia in project NEWROFEED, to a... ver más

31/03/2018

MENSIA

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

MENSIA TECHNOLOGIES No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-03-31

PHC-12-2015: Clinical research for the validatio...

I+D

Cerrada hace 9 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

MENSIA

3.60M€ | Lider

Proyectos interesantes

Brainhero – Embracing Neurodiversity

Medical Technol...

Software

4M€ Cerrado

PSI2013-47506-R

Medical Technol...

Data Science

54K€ Cerrado

KOALA FOCUS

Medical Technol...

Software

71K€ Cerrado

UNSE13-1E-1847

Medical Technol...

Data Science

68K€ Cerrado

NeuroSoNew

Medical Technol...

Data Science

150K€ Cerrado

PGC2018-093785-A-I00

Medical Technol...

Data Science

35K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 29 meses Fecha Inicio: 2015-10-11
Fecha Fin: 2018-03-31

Líder del proyecto

MENSIA TECHNOLOGIES No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto NEWROFEED aims at setting a new standard of care for children suffering from Attention Deficit Hyperactivity Disorder (ADHD). ADHD@Home is the diagnosis and treatment medical device, developed by Mensia in project NEWROFEED, to achieve this goal. In order to optimise success rates, ADHD@Home is based on an EEG biomarker-based personalised medicine approach to treat ADHD children with state-of-the-art personalized Neurofeedback Training. This patient-centered solution is delivered at home, with supervision by ADHD specialists. As an efficacious alternative to treatment by psychoactive medication, the expected clinical outcomes include normalized social behaviour and improved school performance. ADHD@Home delivers physiological lasting normalization of brain activity, using the child’s endogenous neuronal plasticity, to resolve his or her attention and hyperactivity problems. Its unique technology and design enable it to achieve two critical clinical objectives: 1. To identify the root cause of the ADHD for a given child by quantifying, in real-time, deviations in EEG oscillation biomarkers allowing the clinician to select and adjust the Neurofeedback protocols. 2. To deliver the personalized Neurofeedback protocols on an affordable and user-friendly device, enabling optimal training at home under remote medical supervision. This clinical breakthrough is made possible by Mensia’s cloud-based real time quantitative EEG analysis technology. ADHD@Home will be validated for efficacy in the NEWROFEED Clinical Trial. This will pave the way for a successful commercial launch in 2018 to deliver on our promise of efficacious physiological treatment for millions of ADHD children. Thanks to NEWROFEED, Mensia will become a world leader in the field of EEG-based personalised treatment of Central Nervous System disorders; capitalizing on the clinical success of its ADHD@Home device that will generate 65M€ in cumulative revenues by 2022.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores